Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boost.

Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boost.

Item
http://www.wikidata.org/entity/Q43630423
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupLocally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection.Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer.Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.New paradigms and future challenges in radiation oncology: an update of biological targets and technology.Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity.Update on prostate brachytherapy: long-term outcomes and treatment-related morbidity.Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions.Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?Incorporating a compact proton therapy unit into an existing National Cancer Institute-designated comprehensive cancer center.Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer.Parameters predicting for prostate specific antigen response rates at one year post low-dose-rate intraoperative prostate brachytherapy.Distinguishing prostate-specific antigen bounces from biochemical failure after low-dose-rate prostate brachytherapy.
P2860

Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boost.

Item
http://www.wikidata.org/entity/Q43630423
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Equivalent biochemical control ...... roton beam radiotherapy boost.
@en
Equivalent biochemical control ...... roton beam radiotherapy boost.
@nl
type
label
Equivalent biochemical control ...... roton beam radiotherapy boost.
@en
Equivalent biochemical control ...... roton beam radiotherapy boost.
@nl
prefLabel
Equivalent biochemical control ...... roton beam radiotherapy boost.
@en
Equivalent biochemical control ...... roton beam radiotherapy boost.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Equivalent biochemical control ...... roton beam radiotherapy boost.
@en
P2093
P304
P31
P356
10.1016/J.IJROBP.2009.01.029
P407
P433
P478
P50
P577
P698
P921